Cart
sales@molnova.com
Pirozadil
CAS No. 54110-25-7
Pirozadil( —— )
Catalog No. M19963 CAS No. 54110-25-7
Pirozadil is a hypolipidemic agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 25MG | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePirozadil
-
NoteResearch use only, not for human use.
-
Brief DescriptionPirozadil is a hypolipidemic agent.
-
DescriptionPirozadil is a hypolipidemic agent.
-
In Vitro——
-
In VivoPirozadil is a hypolipidemic agent. Pirozadil's effect on increasing cerebral blood flow is almost equal to that of papaverine, less than that of nicardipine and much greater than that of the other hypolipidemic/ antiatherogenic drugs, nicotinic acid and pyridinol carbamate. Pirozadil is also shown to significantly diminish vascular cerebral resistance to a much greater degree than nicotinic acid and pyridinol carbamate.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number54110-25-7
-
Formula Weight527.52
-
Molecular FormulaC27H29NO10
-
Purity>98% (HPLC)
-
SolubilityDMSO: 60 mg/mL need ultrasonic;Water: Insoluble
-
SMILESCOc1cc(cc(OC)c1OC)C(=O)OCc1cccc(COC(=O)c2cc(OC)c(OC)c(OC)c2)n1
-
Chemical Name26-Pyridinediyldimethylene-bis(345-trimethoxybenzoate)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Masana L et al. Treatment of diet-resistant polygenic hypercholesterolaemic patients with a new nicotinate derivative; in vivo and in vitro low density lipoprotein metabolic studies. J Clin Pharmacol. 1989 Mar;29(3):201-6.
molnova catalog
related products
-
EC330
EC330 a novel steroidal LIF inhibitor showed cytotoxicity in various cancer cell lines and NCI-60 cell line panel at low nano-molar range.
-
HG106
HG106, which is anti-inflammatory and may be used to treat the growth of diseases such as malignant tumours caused by mutations in the RAS gene, which is anti-inflammatory and may be used to treat the growth of diseases such as malignant tumours caused by mutations in the RAS gene.
-
Fosravuconazole L-ly...
FosravuconazoleL-lysine ethanolate is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole.
